CD47 and neoplasm: Among various pathophysiologic mechanisms fostering immune evasive tumor behavior, cluster of differentiation 47 (CD47), a transmembrane molecule commonly present on non-malignant hematologic cells, including red blood cells and thrombocytes, has emerged as a promising target.